Clinical and hormonal effects of the new angiotensin II receptor antagonist LRB081

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 2, 1996, Pages 252-258

  Noel B ^a   Del Re, G ^b   Capone, P ^b   Brunner, H R ^a   Nussberger, J ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Menarini Ricerche SpA   (Italy)

Author keywords

Aldosterone; Angiotensin II; Angiotensin receptor blocker; Antihypertensive drugs; Blood pressure; Renin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CATECHOLAMINE; LRB 081; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; PLASMA HALF LIFE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ALDOSTERONE; ANGIOTENSIN II; BLOOD PRESSURE; CATECHOLAMINES; DOUBLE-BLIND METHOD; HORMONES; HUMANS; MALE; PYRIMIDINONES; RECEPTORS, ANGIOTENSIN; REGIONAL BLOOD FLOW; RENIN; THIOPHENES;

EID: 0029774383     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199608000-00011     Document Type: Article

References (19)

1. Brunner HR, Nussberger J, Waeber B. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system. J Hypertens 1993;11 (suppl 3):S53-8.
2. Weber MA, Byyny RL, Pratt H, et al. Blood pressure effect -of the angiotensin II receptor blocker, Losartan. Arch Intern Med 1995;155:405-1.
3. Crozier I, Ikram H, Awan N, et al. Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemody-namic Study Group. Circulation 1995;91:691-7.
4. Penaz J. Photoelectric measurement of blood pressure, volume and flow in the finger. In: Digest of the 10th International Conference on Medical Engineering. Dresden: 1973:104.
5. Molhoek GP, Wesseling KH, Settels JJM, et al. Evaluation of the Penaz servo-plethysmo-manometer for the continuous, non-invasive measurement of the finger blood pressure. Basic Res Cardiol 1984;79:598-609.
6. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure mon itoring at rest and during laboratory testing. Hypertension 1989;13:647-55.
7. Christen Y, Waeber B, Nussberger J, Brunner HR. Non-invasive blood pressure monitoring at the finger for studying short-lasting pressor responses in man. J Clin Pharmacol 1990;30:711-4.
8. Nussberger J, Waeber B, Brunner HR, Burris JF, Vetter W. Highly sensitive microassay for aldosterone in unextracted plasma: comparison with two other methods. J Lab Clin Med 1984;104:789-96.
9. Nussberger J, Fasanella D'Amore T, et al. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol 1987;9:39-44.
10. Poulsen K, Jörgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate inhuman and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Pharmacol 1987;39: 816-25.
11. Nussberger J, Keller I, Waeber B, Brunner HR. Angiotensin II measurement with high-affinity monoclonal antibodies. J Hypertens 1988;6(suppl 4):S424-5.
12. Peuler JD, Johnson GA. Simultaneous simple isotope radio-enzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977;21:625-36.
13. Munafo A, Christen Y, Nussberger J, et al. Drug concentration response relationships in normal volunteers after oral administration of losartan, and angiotensin II receptor antagonist. Clin Pharmacol Ther 1992;51:513-21.
14. Weber M: Clinical experience with the angiotensin II receptor antagonist losartan. Am J Hypertens 1992;5:247S-51S.
15. Donnelly R, Elliot HL, Meredith PA. Concentration-effect analysis of antihypertensive drug response. Clin Pharmacokinet 1994;26:472-85.
16. Laragh JH, Case DB, Atlas SA, Sealey JE: Captopril compared to other anti-renin agents in hypertensive patients - its triphasic effect on blood pressure and its use to identify and treat the renin factor. Hypertension 1980;2:586-93.
17. Wong PC, Price WA, Chiu AT, et al. Non peptide angiotensin II receptor antagonists: XI. Pharmacology of EXP 3174, an active metabolite of DUP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990;255:211-7.
18. Delacrétaz E, Nussberger J, Biollaz J, Waeber B, Brunner HR. Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers. Hypertension 1995;25: 14-21.
19. Mooser V, Nussberger J, Juillerat L, et al. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J Cardiovasc Pharmacol 1990;15: 276-82.